Seyed Mohammad Taghdisi Selected Research

AGRO 100

12/2022	A multi-storey DNA nanostructure containing doxorubicin and AS1411 aptamer for targeting breast cancer cells.
1/2022	Design and synthesis of a star-like polymeric micelle modified with AS1411 aptamer for targeted delivery of camptothecin for cancer therapy.
1/2022	Fabrication of anionic dextran-coated micelles for aptamer targeted delivery of camptothecin and survivin-shRNA to colon adenocarcinoma.
2/2021	Ladder-like targeted and gated doxorubicin delivery using bivalent aptamer in vitro and in vivo.
1/2021	Fabrication of versatile targeted lipopolymersomes for improved camptothecin efficacy against colon adenocarcinoma in vitro and in vivo.
11/2020	Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
8/2020	A smart ATP-responsive chemotherapy drug-free delivery system using a DNA nanostructure for synergistic treatment of breast cancer in vitro and in vivo.
7/2020	Therapeutic applications of AS1411 aptamer, an update review.
1/2019	High affinity of AS1411 toward copper; its application in a sensitive aptasensor for copper detection.
11/2018	Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seyed Mohammad Taghdisi Research Topics

Disease

64	Neoplasms (Cancer) 09/2022 - 02/2011
16	Breast Neoplasms (Breast Cancer) 12/2022 - 06/2015
11	Colonic Neoplasms (Colon Cancer) 01/2022 - 10/2013
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2011
7	Adenocarcinoma 07/2022 - 11/2016
7	Carcinoma (Carcinomatosis) 12/2021 - 01/2016
7	Cardiotoxicity 05/2016 - 05/2010
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2017 - 05/2010
5	Leukemia 01/2017 - 05/2010
2	Neoplasm Metastasis (Metastasis) 07/2022 - 07/2018
2	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 01/2019
2	Myocardial Infarction 06/2016 - 04/2016
1	Prostatic Neoplasms (Prostate Cancer) 08/2022
1	Dementia (Dementias) 02/2022
1	Nervous System Diseases (Neurological Disorders) 02/2022
1	Amyloid Plaque 02/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2021
1	Inflammation (Inflammations) 12/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2020

Drug/Important Bio-Agent (IBA)

23	Pharmaceutical PreparationsIBA 07/2022 - 05/2010
17	AGRO 100IBA 12/2022 - 05/2016
15	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 01/2018
12	APTIBA 09/2022 - 10/2013
11	Biomarkers (Surrogate Marker)IBA 08/2022 - 02/2011
10	NucleolinIBA 01/2021 - 01/2017
9	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 08/2017
9	Epirubicin (Ellence)FDA LinkGeneric 01/2022 - 09/2013
8	CamptothecinIBA 01/2022 - 03/2017
7	Nucleotide AptamersIBA 10/2021 - 06/2015
6	Adenosine Triphosphate (ATP)IBA 02/2021 - 05/2016
6	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 06/2017
5	GoldIBA 11/2020 - 07/2015
4	PolymersIBA 07/2022 - 03/2019
4	Peptides (Polypeptides)IBA 02/2022 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 02/2022 - 07/2018
4	MicellesIBA 01/2022 - 01/2018
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022 - 11/2020
4	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2016 - 05/2010
3	Dextrans (Dextran)FDA Link 01/2022 - 10/2017
3	Epithelial Cell Adhesion MoleculeIBA 12/2021 - 06/2017
3	ChitosanIBA 11/2020 - 01/2017
3	LigandsIBA 09/2020 - 06/2015
3	Dendrimers (Dendrons)IBA 10/2018 - 05/2016
2	PicoGreenIBA 08/2022 - 09/2019
2	Fluorescent Dyes (Fluorescent Probes)IBA 08/2022 - 09/2019
2	Cruciform DNA (Holliday Junctions)IBA 08/2022 - 11/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 11/2018
2	SurvivinIBA 01/2022 - 11/2020
2	Small Interfering RNA (siRNA)IBA 01/2022 - 11/2020
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2022 - 04/2019
2	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 12/2020 - 10/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2020 - 11/2016
2	EnzymesIBA 09/2020 - 01/2019
2	Melitten (Melittin)IBA 04/2019 - 06/2018
2	CurcuminIBA 10/2018 - 10/2017
2	IntegrinsIBA 01/2018 - 10/2017
2	5TR1 aptamerIBA 01/2018 - 01/2017
2	graphene oxideIBA 06/2017 - 01/2017
2	MyoglobinIBA 06/2016 - 04/2016
2	AnthracyclinesIBA 01/2016 - 09/2013
1	Prostate-Specific Antigen (Semenogelase)IBA 08/2022
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 07/2022
1	adhesion receptorIBA 07/2022
1	Amyloid (Amyloid Fibrils)IBA 02/2022
1	Ferritins (Ferritin)IBA 01/2022
1	SolventsIBA 12/2021
1	Metal-Organic FrameworksIBA 03/2021
1	SiderophoresIBA 01/2021
1	pyoverdinIBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2020
1	Hematoxylin (Haematoxylon)IBA 12/2020
1	ResveratrolIBA 12/2020
1	Transcription Factors (Transcription Factor)IBA 12/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2020
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 09/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2020
1	poly(lactide) (polylactic acid)IBA 09/2020
1	A-Form DNA (A-DNA)IBA 08/2020
1	GadoliniumIBA 03/2020
1	CarbonIBA 01/2020
1	BromidesIBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 12/2019
1	StreptavidinIBA 09/2019
1	MicroRNAs (MicroRNA)IBA 09/2019
1	Calcium Carbonate (Limestone)FDA Link 04/2019
1	Glycoproteins (Glycoprotein)IBA 04/2019
1	EstersIBA 03/2019
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 03/2019
1	OligonucleotidesIBA 03/2019
1	Nucleic AcidsIBA 01/2019
1	LipidsIBA 01/2019
1	SynucleinsIBA 01/2019

Therapy/Procedure

26	Therapeutics 01/2022 - 10/2013
10	Drug Therapy (Chemotherapy) 01/2022 - 10/2013
8	Precision Medicine 01/2022 - 06/2017
2	Intravenous Injections 01/2022 - 11/2020
1	Oral Administration 12/2020
1	Quantum Dots (Quantum Dot) 03/2020